Development of Syringaldehyde as an Agonist of the GLP-1 Receptor to Alleviate Diabetic Disorders in Animal Models
Article in Pharmaceuticals (April 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Pharmaceuticals (April 2024)
Article in World Journal of Diabetes (January 2024)
Article in Profilakticheskaya meditsina (January 2024)